Summary of clonal heterogeneity and clonal persistence in MF patients
| . | Common GR . | Different GR . | No GR . |
|---|---|---|---|
| Concurrent skin samples | 11 patients (65%) (additional GRs in 5/11) | 4 patients (24%) | 2 patients (11%) |
| Sequential skin samples | 18 patients (82%) (additional GRs in 5/18) | 2 patients (9%) | 2 patients (9%) |
| Skin/lymph node samples | 8 patients (73%) | 2 patients (18%) | 1 patient (9%) |
| . | Common GR . | Different GR . | No GR . |
|---|---|---|---|
| Concurrent skin samples | 11 patients (65%) (additional GRs in 5/11) | 4 patients (24%) | 2 patients (11%) |
| Sequential skin samples | 18 patients (82%) (additional GRs in 5/18) | 2 patients (9%) | 2 patients (9%) |
| Skin/lymph node samples | 8 patients (73%) | 2 patients (18%) | 1 patient (9%) |